. 2014 Jun 30;35(8):1031–1044. doi: 10.1038/aps.2014.41

Table 1. Serum parameters in control rats and CCl₄ rats receiving Rg1, bicyclol, or vehicle (DDW) treatment. Data are presented as mean±SD. ^cP<0.01 compared with control. ^eP<0.05, ^fP<0.01 compared with CCl₄ alone.

Groups	ALT (U/L)	AST (U/L)	LDH (U/L)	ALP (U/L)
Control (n=6)	27.3±2.3	145.3±18.8	363.0±70.5	149.5±15.8
CCl₄ (n=10)	439.2±97.1^c	780.9±134.8^c	847.8±125.9^c	454.7±44.1^c
CCl₄+Rg1 10 mg (n=10)	355.9±75.5	588.3±79.4	555.3±93.4^e	403.6±49.4
CCl₄+Rg1 20 mg (n=9)	178.5±23.8^f	398.9±63.9^f	459.3±88.4^f	324.8±51.3^e
CCl₄+Rg1 40 mg (n=10)	159.6±23.6^f	295.1±36.2^f	378.4±39.3^f	290.4±37.5^f
CCl₄+Bicyclol (n=9)	39.2±3.1^f	271.0±29.2^f	583.4±43.3^e	298.8±35.4^e

Table 1. Serum parameters in control rats and CCl4 rats receiving Rg1, bicyclol, or vehicle (DDW) treatment. Data are presented as mean±SD. cP<0.01 compared with control. eP<0.05, fP<0.01 compared with CCl4 alone.